Correlation Between 4D Molecular and Applied Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Applied Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Applied Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Applied Therapeutics, you can compare the effects of market volatilities on 4D Molecular and Applied Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Applied Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Applied Therapeutics.

Diversification Opportunities for 4D Molecular and Applied Therapeutics

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between FDMT and Applied is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Applied Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Applied Therapeutics and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Applied Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Applied Therapeutics has no effect on the direction of 4D Molecular i.e., 4D Molecular and Applied Therapeutics go up and down completely randomly.

Pair Corralation between 4D Molecular and Applied Therapeutics

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 1.07 times more return on investment than Applied Therapeutics. However, 4D Molecular is 1.07 times more volatile than Applied Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Applied Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  472.00  in 4D Molecular Therapeutics on November 27, 2024 and sell it today you would lose (20.00) from holding 4D Molecular Therapeutics or give up 4.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Applied Therapeutics

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Applied Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Applied Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

4D Molecular and Applied Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Applied Therapeutics

The main advantage of trading using opposite 4D Molecular and Applied Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Applied Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied Therapeutics will offset losses from the drop in Applied Therapeutics' long position.
The idea behind 4D Molecular Therapeutics and Applied Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data